Publication: 183

Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 26 (6) 870-876
Year:
2008
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
801  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, CA77597, CA11789, CA77406, CA47577, CA35113, CA32291, P30 CA006973, CA41287, U10 CA031946, U10 CA033601, CA45389, CA45808, CA16450, CA77440, CA45564, CA04326, CA21060, CA47642, CA45418, CA77298, CA31983, CA31946  
Corr. Author:
 
Authors:
               
Networks:
 
Study
CALGB-30103
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Article